Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. The collaboration is designed to identify clinically diffe…
Eurobio Scientific, a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, announces that it has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitutes the Lab Products division of CareDx, Inc., a…
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings Pte.Ltd., Singapore, have signed a Memorandum of Understanding (MoU) to establish a strategic Joint Venture aimed at expanding access to high-quality healthcare solutions across South-East Asia and selected intern…
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced an expanded strategic collaboration with a leading US-based biopharmaceutical company. The expansion adds two biologics programs to be produced commercially, with the option for two more, and further strengthens an estab…
Merck, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, entered into a definitive agreement pursuant to which Merck will, subject to customary closing conditions, acquire Bio-Techne for US$73 per s…
Antares Therapeutics, Inc., a biotechnology company developing first-in-class precision medicines for cancer and other serious diseases, announced a strategic collaboration with Novartis to discover, develop and commercialize small molecule therapies against promising but historically undruggable oncology targets. The…
Agilent Technologies Inc. announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life S…
Abbisko Therapeutics Co., Ltd. announced that it has entered into a strategic research collaboration and license agreement with Eli Lilly and Company, a leading global pharmaceutical company. Under the agreement, the two companies will collaborate on the discovery and development of innovative medicines across multipl…
Evonik is selling selected production assets for pharmaceutical ingredients in Hanau, Germany to the contract manufacturer ProChem Group. By acquiring the facilities, the ProChem Group will strengthen its production capabilities, enhance its technological expertise, and expand its services to pharmaceutical customers.…
AbbVie and Apogee Therapeutics announced they have entered into a definitive agreement under which AbbVie will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development across inflammatory and immunological diseases, including atopic dermatitis (AD) and asthma. The acquisition comple…
Page 11 of 43